📋 XTANT MEDICAL HOLDINGS, INC. (XTNT) - Financial Results
Filing Date: 2026-08-11
Accepted: 2026-08-11 07:05:26
Event Type: Financial Results
Event Details:
XTANT MEDICAL HOLDINGS, INC. (XTNT) Reports the reporting period Financial Results
XTANT MEDICAL HOLDINGS, INC. (XTNT) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 10368
Net Income: $3
EPS: Not disclosed
Cash and equivalents: 9870
performance hemostasis following certain surgical procedures. As part of the transaction, Xtant has hired Dilon’s approximately 20
person U.S. sales team, who will support Xtant’s entire biologics portfolio. ●Launched Trivium™ Shaped, an extension of its Trivium line of premium, next
generation demineralized bone matrix allograft for bone grafting procedures. Trivium™ Shaped is available in pre
📋 XTANT MEDICAL HOLDINGS, INC. (XTNT) - Financial Results
Filing Date: 2026-08-11
Accepted: 2026-08-11 07:05:26
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: